Hrt Financial LP Regeneron Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $4.51 Million - $4.96 Million	4,992 Added 82.29%	11,058 $10.6 Million
Q4 2023 Feb 09, 2024	SELL	$775.18 - $881.7 $3.56 Million - $4.05 Million	-4,590 Reduced 43.07%	6,066 $5.33 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $7.38 Million - $9 Million	10,656 New	10,656 $8.77 Million
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $28.7 Million - $31.2 Million	40,648 New	40,648 $29.3 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $9.7 Million - $12 Million	-17,847 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $2.24 Million - $2.65 Million	3,896 Added 27.93%	17,847 $10.8 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $830,236 - $980,796	-1,756 Reduced 11.18%	13,951 $7.79 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $7.02 Million - $8.61 Million	15,707 New	15,707 $7.43 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $1.28 Million - $1.89 Million	-3,815 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $410,372 - $563,635	1,497 Added 64.58%	3,815 $1.43 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $633,880 - $738,028	2,318 New	2,318 $643,000
Q4 2018 Feb 15, 2019	SELL	$335.82 - $403.04 $677,684 - $813,334	-2,018 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$351.14 - $408.51 $708,600 - $824,373	2,018 New	2,018 $815,000
Q2 2018 Aug 15, 2018	SELL	$284.6 - $344.99 $287,446 - $348,439	-1,010 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$315.82 - $393.78 $318,978 - $397,717	1,010 New	1,010 $347,000

1,463

84.5M

907K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.